Shanshan Deng

1.2k total citations
33 papers, 918 citations indexed

About

Shanshan Deng is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Shanshan Deng has authored 33 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 11 papers in Organic Chemistry. Recurrent topics in Shanshan Deng's work include Synthesis and biological activity (10 papers), Cancer therapeutics and mechanisms (5 papers) and Microtubule and mitosis dynamics (4 papers). Shanshan Deng is often cited by papers focused on Synthesis and biological activity (10 papers), Cancer therapeutics and mechanisms (5 papers) and Microtubule and mitosis dynamics (4 papers). Shanshan Deng collaborates with scholars based in United States, China and Lebanon. Shanshan Deng's co-authors include Wěi Li, Najah Albadari, Duane D. Miller, Hao Chen, Souvik Banerjee, Kinsie E. Arnst, Stephen W. White, Dong‐Jin Hwang, Yuxi Wang and Lei Yang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Shanshan Deng

30 papers receiving 910 citations

Peers

Countries citing papers authored by Shanshan Deng

Since Specialization

Citations

This map shows the geographic impact of Shanshan Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanshan Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanshan Deng more than expected).

Fields of papers citing papers by Shanshan Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanshan Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanshan Deng. The network helps show where Shanshan Deng may publish in the future.

Co-authorship network of co-authors of Shanshan Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Shanshan Deng. A scholar is included among the top collaborators of Shanshan Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanshan Deng. Shanshan Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overnight-dwelled amino acid-based peritoneal dialysis solutions for malnutrition in CAPD: a prospective real-world study 2025 ·International Urology and Nephrology ·Shanshan Deng, (unknown), Li-Ling Chen, Xiaoyan Su, Yong Su, (unknown), Mingsheng Zhu, Xiaoxia Yang, (unknown), (unknown)	0
2	Real-world insights from acute management of potassium disorders in diabetic ketoacidosis 2025 ·Frontiers in Endocrinology ·Yue Zhang, Jing Li, Shanshan Deng, Yongjing Zhang, Manli Guo, (unknown), (unknown), Yanqing He, Shao-Gang Ma, (unknown)	0
3	Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer 2024 ·Cancer Letters ·(unknown), (unknown), Raisa I. Krutilina, Hao Chen, (unknown), Shanshan Deng, Deanna N. Parke, John L. Abernathy, (unknown), (unknown), (unknown), Dejian Ma, Bernd Meibohm, Duane D. Miller, Tiffany N. Seagroves, Wěi Li	1
4	Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19 2023 ·Frontiers in Cellular and Infection Microbiology ·Zhan Gao, (unknown), Ling Cao, Meng Yang, Yuhui Li, Yue Lan, Ruixiang Tang, Yang Huang, (unknown), (unknown), (unknown), Jian Ling, (unknown), Zhenxin Fan, Yujiao Bai, Mei Luo, Miao He, Shanshan Deng	2
5	Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer 2022 ·Molecular Cancer Therapeutics ·Shanshan Deng, Raisa I. Krutilina, (unknown), Hao Chen, Deanna N. Parke, (unknown), (unknown), Dejian Ma, (unknown), Bernd Meibohm, Tiffany N. Seagroves, Duane D. Miller, Wěi Li	12
6	SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis 2022 ·Cancer Letters ·Shanshan Deng, Souvik Banerjee, Hao Chen, (unknown), Yuxi Wang, Mi‐Kyung Yun, Stephen W. White, (unknown), Bernd Meibohm, (unknown), Zhongzhi Wu, Duane D. Miller, Wěi Li	18
7	pH-sensitive nanomedicine of novel tubulin polymerization inhibitor for lung metastatic melanoma 2022 ·Journal of Controlled Release ·Rajan Sharma Bhattarai, Jitender Bariwal, Virender Kumar, Hao Chen, Shanshan Deng, Wěi Li, Ram I. Mahato	9
8	Synthesis and biological evaluation of selective survivin inhibitors derived from the MX-106 hydroxyquinoline scaffold 2021 ·European Journal of Medicinal Chemistry ·Najah Albadari, Shanshan Deng, Hao Chen, Guannan Zhao, Junming Yue, Sicheng Zhang, Duane D. Miller, Zhongzhi Wu, Wěi Li	5
9	Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models 2021 ·Frontiers in Oncology ·Shanshan Deng, Antonio Solinas, Diego F. Calvisi	24
10	Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway 2021 ·Frontiers in Pharmacology ·(unknown), (unknown), Qian Zhang, Shanshan Deng, Dahai Yu, Yuefan Zhang, Tiejun Li	45
11	Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer 2020 ·Carcinogenesis ·Shanshan Deng, (unknown), (unknown), (unknown), (unknown), (unknown), Yiping Dong, (unknown), (unknown), Mauricio S. Caetano, Shuanying Yang, Edwin J. Ostrin, Carmen Behrens, Ignacio I. Wistuba, Laura P. Stabile, Humam Kadara, Stephanie S. Watowich, Seyed Javad Moghaddam	13
12	Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors 2020 ·Bioorganic Chemistry ·Souvik Banerjee, Derek D. Norman, Shanshan Deng, Sayo O. Fakayode, Sue Çhin Lee, Abby L. Parrill, Wěi Li, Duane D. Miller, Gábor Tigyi	6
13	Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment 2020 ·Frontiers in Oncology ·Shanshan Deng, (unknown), (unknown), (unknown), Seyed Javad Moghaddam	30
14	Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer 2020 ·Journal of Controlled Release ·Rajan Sharma Bhattarai, Virender Kumar, Svetlana Romanova, Jitender Bariwal, Hao Chen, Shanshan Deng, Vijaya Raj Bhatt, Tatiana K. Bronich, Wěi Li, Ram I. Mahato	10
15	Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer 2020 ·Cancer Letters ·Foyez Mahmud, Shanshan Deng, Hao Chen, Duane D. Miller, Wěi Li	25
16	An Orally Available Tubulin Inhibitor, VERU-111, Suppresses Triple-Negative Breast Cancer Tumor Growth and Metastasis and Bypasses Taxane Resistance 2019 ·Molecular Cancer Therapeutics ·Shanshan Deng, Raisa I. Krutilina, Qinghui Wang, Zongtao Lin, Deanna N. Parke, (unknown), Hao Chen, Duane D. Miller, Tiffany N. Seagroves, Wěi Li	35
17	Structure–Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties 2019 ·Journal of Medicinal Chemistry ·Hao Chen, Shanshan Deng, Yuxi Wang, Najah Albadari, Gyanendra Kumar, Dejian Ma, Weimin Li, Stephen W. White, Duane D. Miller, Wěi Li	40
18	The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy 2019 ·Expert Opinion on Drug Discovery ·Najah Albadari, Shanshan Deng, Wěi Li	263
19	Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer 2018 ·Nature Communications ·Mauricio S. Caetano, Maya Hassane, (unknown), (unknown), Amber M. Cumpian, (unknown), (unknown), Huiyuan Zhang, Shanshan Deng, Lixia Diao, Jing Wang, Scott E. Evans, Carmen Behrens, Ignacio I. Wistuba, (unknown), Lin Huang, Laura P. Stabile, Stephanie S. Watowich, Humam Kadara, Seyed Javad Moghaddam	51
20	A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis 2010 ·Biochemical and Biophysical Research Communications ·Rui Liu, Yiming Li, (unknown), Tianru Jin, Shanshan Deng, (unknown), Nina Zhang, Jinzhong Chen, Gérald J. Prud’homme, William Jia, Duan Ma, Qinghua Wang	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact